Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.

NBEAL2 encodes a multidomain scaffolding protein with a putative role in granule ontogeny in human platelets. Mutations in NBEAL2 underlie gray platelet syndrome (GPS), a rare inherited bleeding disorder characterized by a lack of α-granules within blood platelets and progressive bone marrow fibrosis. We present here a novel Nbeal2(-/-) murine model of GPS and demonstrate that the lack of α-granules is due to their loss from platelets/mature megakaryocytes (MKs), and not by initial impaired formation. We show that the lack of Nbeal2 confers a proinflammatory phenotype to the bone marrow MKs, which in combination with the loss of proteins from α-granules drives the development of bone marrow fibrosis. In addition, we demonstrate that α-granule deficiency impairs platelet function beyond their purely hemostatic role and that Nbeal2 deficiency has a protective effect against cancer metastasis.

[1]  H. Hasselbalch.  The role of cytokines in the initiation and progression of myelofibrosis. , 2013, Cytokine & growth factor reviews.

[2]  N. Debili,et al.  Multivesicular Bodies Are an Intermediate Stage in the Formation of Platelet α-Granules , 1998 .

[3]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[4]  White Jg.  Ultrastructural studies of the gray platelet syndrome. , 1979 .

[5]  G. Raccuglia.  Gray platelet syndrome. A variety of qualitative platelet disorder. , 1971, The American journal of medicine.

[6]  A. Green,et al.  JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia. , 2013, Blood.

[7]  Jurgen Del-Favero,et al.  SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. , 2010, Human molecular genetics.

[8]  Ajit Varki,et al.  Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Callewaert,et al.  P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. , 2007, Glycobiology.

[10]  Gianni Tognoni,et al.  Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials , 2012, The Lancet.

[11]  References , 1971 .

[12]  J. Harrow,et al.  A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.

[13]  D. Maynard,et al.  The α‐granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome , 2010, Journal of thrombosis and haemostasis : JTH.

[14]  V. Seshan,et al.  A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis , 2012, Cell.

[15]  P. Bork,et al.  Identification and mutation analysis of the complete gene for Chediak–Higashi syndrome , 1996, Nature Genetics.

[16]  C P Charles.  National Health Service. , 1971, The Medical journal of Australia.

[17]  G. Cagney,et al.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.

[18]  P. Nurden,et al.  The gray platelet syndrome: clinical spectrum of the disease. , 2007, Blood reviews.

[19]  W. Vainchenker,et al.  Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. , 1985, Blood.

[20]  S. Russell,et al.  Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation. , 2009, Blood.

[21]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Nurden,et al.  Platelets and wound healing. , 2008, Frontiers in bioscience : a journal and virtual library.

[23]  A. Varki,et al.  P-selectin deficiency attenuates tumor growth and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Ambrosio,et al.  Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system. , 2012, Blood.

[25]  Richard W. Farndale,et al.  Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.

[26]  F. Wendling,et al.  Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. , 2000, Blood.

[27]  J. Mullikin,et al.  NBEAL2 is mutated in Gray Platelet Syndrome and is required for biogenesis of platelet alpha-granules , 2011, Nature Genetics.

[28]  R. Jain,et al.  Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Flaumenhaft,et al.  Platelet alpha-granules: basic biology and clinical correlates. , 2009, Blood reviews.

[30]  E. Battinelli,et al.  Selective sorting of alpha‐granule proteins , 2009, Journal of thrombosis and haemostasis : JTH.

[31]  B. Storrie,et al.  Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release , 2007, Journal of thrombosis and haemostasis : JTH.

[32]  R. Ramirez-Solis,et al.  Molecular Characterization of Mutant Mouse Strains Generated from the EUCOMM/KOMP-CSD ES Cell Resource , 2013, Mammalian Genome.

[33]  A. Tefferi,et al.  Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Ware,et al.  Platelets: Linking Hemostasis and Cancer , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[35]  W. Vainchenker,et al.  Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. , 1981, The American journal of pathology.

[36]  Damian Smedley,et al.  Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes , 2013, Cell.

[37]  David R. Nadeau,et al.  Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Suva,et al.  Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells , 2011, Breast Cancer Research.

[39]  U. Schumacher,et al.  E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung , 2009, British Journal of Cancer.

[40]  T. Kieber‐Emmons,et al.  Chondroitin sulfate glycosaminoglycans as major P‐selectin ligands on metastatic breast cancer cell lines , 2007, International journal of cancer.

[41]  S. Jackson.  Arterial thrombosis—insidious, unpredictable and deadly , 2011, Nature Medicine.

[42]  T. Barbui,et al.  JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations , 2011, Leukemia.

[43]  C. Hawkins,et al.  Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. , 2013, Blood.

[44]  Gregory E. Jordan,et al.  Exome sequencing identifies NBEAL2 as the causative gene for Gray Platelet Syndrome , 2011, Nature Genetics.

[45]  Joseph E Italiano,et al.  The biogenesis of platelets from megakaryocyte proplatelets. , 2005, The Journal of clinical investigation.

[46]  J. White,et al.  A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. , 2001, Molecular genetics and metabolism.

[47]  J. Parkinson,et al.  Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome , 2011, Nature Genetics.

[48]  N. Debili,et al.  Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. , 1998, Blood.

[49]  W. Mitchell,et al.  Ex Vivo production of platelets from stem cells , 2014, British journal of haematology.

[50]  J. Freedman,et al.  Platelets and the immune continuum , 2011, Nature Reviews Immunology.